• About Us
  • Contact Us
Cure IBM
  • Home
  • IBM FAQ
  • Diagnosis
    • Introduction
    • Symptoms
    • Examination
    • Blood Tests
    • Electromyogram (EMG) and Nerve Conduction Studies
    • Magnetic Resonance Imaging (MRI)
    • Muscle Biopsy
    • Misdiagnosis
  • Treatment
    • Introduction
    • Medications
    • Clinical Trials
    • Exercise
    • Nutrition and Weight Control
    • Falls
    • Swallowing
    • Psychology
  • Resources
    • Links
    • Glossary
  • IBM Blog
  • Donate
Menu
Arimoclomol for Inclusion Body Myositis – Clinical Trial Results

Arimoclomol for Inclusion Body Myositis – Clinical Trial Results

by Kevin Dooley, MD | Mar 30, 2021 | News and Information

Negative Results The biotech company Orphazyme announced negative results yesterday for the clinical trial of arimoclomol in the treatment of inclusion body myositis (IBM). The drug failed to meet the primary and secondary endpoints which were used to measure success....
$68,245 Grant Available for Study of Inclusion Body Myositis

$68,245 Grant Available for Study of Inclusion Body Myositis

by Kevin Dooley, MD | Aug 26, 2020 | News and Information

The Orphan Disease Center 2020 Million Dollar Bike Ride Grant Program is offering a $68,245 grant for the study of inclusion body myositis (IBM). Researchers from around the world are eligible to apply. Letters of Interest are due Friday, September 18. The grant is...
You can Bike, Walk, Run, or Ride for IBM on Saturday, June 13!

You can Bike, Walk, Run, or Ride for IBM on Saturday, June 13!

by Kevin Dooley, MD | Jun 10, 2020 | News and Information

JOIN US! On June 13, you can support the cause of inclusion body myositis by biking, walking, running, swimming, or riding in your own town or city. The Million Dollar Bike Ride has become a virtual event this year. Although it is unfortunate that Team Cure IBM cannot...
The Million Dollar Bike Ride Needs YOUR Help!

The Million Dollar Bike Ride Needs YOUR Help!

by Kevin Dooley, MD | Apr 14, 2020 | News and Information

Due to the coronavirus pandemic, Team Cure IBM will not be able to ride our bikes in Philadelphia this summer. However, although the University of Pennsylvania, the sponsor of the Million Dollar Bike Ride (MDBR), has cancelled the ride, the MDBR will still continue as...
AAVogen Seeks Investment Funding for Development of New Therapy to Treat Inclusion Body Myositis

AAVogen Seeks Investment Funding for Development of New Therapy to Treat Inclusion Body Myositis

by Kevin Dooley, MD | Mar 19, 2020 | News and Information

AAVogen, an early-stage biotech company, is developing a new treatment for inclusion body myositis (IBM). AVGN7 is a novel gene therapy treatment that is designed to treat IBM and other muscle wasting conditions. AAVogen has raised $2.3 million to date, mostly from...
« Older Entries

Recent Posts

  • Medicare Seeks Public Comments as it Considers Expanding Benefits to Include Seat Elevators for Power Wheelchairs
  • The IndeeLift and Inclusion Body Myositis
  • Arimoclomol for Inclusion Body Myositis – Clinical Trial Results
  • $68,245 Grant Available for Study of Inclusion Body Myositis
  • You can Bike, Walk, Run, or Ride for IBM on Saturday, June 13!

Archives

  • September 2022
  • July 2021
  • March 2021
  • August 2020
  • June 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • April 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017

Tags

actvin a advocacy arimoclomol asking for help atrophy biomarker chloroquine clinical trial clinical trial endpoints clinical trials coronavirus COVID-19 Electrical Impedance Myography falls FDA fundraising hand function helpful devices IBMFRS IB Myositis YouTube Channel Inclusion Body Myositis Functional Rating Scale IndeeLift inflammation Late stage IBM Living with IBM MDBR Million Dollar Bike Ride mitochondria mri muscle biopsies muscle biopsy muscle degeneration muscle strength myositis clinic myostatin NT5C1A patient story personal story positive attitude rapamycin research specialty care sporadic inclusion body myositis wheelchairs Yale
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Facebook
  • Twitter

© 2023 Cure IBM | Website design and digital media services by Abaton Consulting